Hua Er Jie Jian Wen·2025-08-20 11:21Core Changes - Shareholder Change: Baker Brothers Life Sciences, L.P. and its affiliates reduced their shareholding from 8.06% to 7.99%, a decrease of 0.07 percentage points [1] - Share Count Unchanged: The number of shares held remains at 115,666,055, indicating passive dilution [1] Reason for Change - Date: August 19, 2025 [1] - Specifics: The company's subsidiary BG NC 2, Ltd. transferred 13 million common shares to a custodian in exchange for an equivalent number of American Depositary Shares [1] - Purpose: This transfer is intended to fulfill unvested equity awards under the 2016 option and incentive plan [1] Important Notes - No Change in A-Shares: This change does not affect the number of A-shares [1] - No Trigger for Mandatory Offer: The change does not trigger any mandatory offer obligations [1] - Governance Structure Unchanged: There is no alteration in the company's governance structure [1] - No Need for Disclosure: There is no requirement to disclose an equity change report or related documents [1] - Passive Dilution: The change is classified as passive dilution due to share issuance, with no actual change in the number of shares held by the shareholder [1]